InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,304.72
(
0.70%
)
US TECH 100
18,318.00
(
0.95%
)
Dow Jones
39,069.59
(
0.01%
)
Brent Oil
81.97
(
0.00%
)
Bitcoin
69,170.00
(
-0.14%
)
Post# of 251939
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DonShimoda

Send PM Follow Ignore
Followers 19
Posts 727
Boards Moderated 0
Alias Born 11/10/2009

DonShimoda

Re: JJM760 post# 127813

Wednesday, 10/05/2011 10:07:32 AM

Wednesday, October 05, 2011 10:07:32 AM

Post# of 251939
Irregardless of how MRK proceeds with Rida, I'm just glad that ARIA off-loaded 50% of its development costs for a lower % of the topline (as opposed to the shared cost/bottomline royalty deal they originally structured). imo, this has allowed the company to retain control of two far more promising drugs - ponatinib and AP113 - without incurring additional dilution (so far).
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up